Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 1
Submit an article Journal homepage
28
Views
1
CrossRef citations to date
0
Altmetric
Case Studies

Acute myocardial infarction in a young man with large left ventricular thrombus and the antiphospholipid syndrome

Mohamed AyanDepartment of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3672-1881
, MBBCh ORCID Icon,
Yazeid AlshebaniDepartment of Cardiovascular Medicine, CHI Health, Creighton University School of Medicine, Omaha, Nebraska;
, MBBCh,
Hamza TantoushDepartment of Rheumatology, University of South Dakota, Sioux Falls, South Dakota;
, MBBCh,
Mohsin SalihDepartment of Internal Medicine, University of Kentucky, Lexington, Kentucky;
, MBBCh,
Waiel AbusninaDepartment of Internal Medicine, Marshall University, Huntington, West Virginia; ORCID Iconhttp://orcid.org/0000-0003-2617-8483
, MD ORCID Icon,
Mansour KhaddrDepartment of Cardiovascular Medicine, University of Connecticut–Farmington, Farmington, Connecticut
, MD &
Aiman SmerDepartment of Cardiovascular Medicine, CHI Health, Creighton University School of Medicine, Omaha, Nebraska;
, MBBCh show all
Pages 110-112 | Received 13 Jun 2018, Accepted 19 Jul 2018, Published online: 13 Nov 2018

  • Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306. doi:10.1111/j.1538-7836.2006.01753.x.
  • Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019–1027. doi:10.1002/art.10187.
  • Denas G, Jose SP, Bracco A, Zoppellaro G, Pengo V. Antiphospholipid syndrome and the heart: A case series and literature review. Autoimmun Rev. 2015;14(3):214–222. doi:10.1016/j.autrev.2014.11.003.
  • Turiel M, Sarzi-Puttini P, Peretti R, et al. Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol. 2005;96(4):574–579. doi:10.1016/j.amjcard.2005.04.022.
  • Cervera R, Tektonidou MG, Espinosa G, et al. Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): Catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011;20(2):165–173. doi:10.1177/0961203310395051.
  • Marti V, Seixo F, Santalo M, Serra A. Antiphospholipid syndrome and acute myocardial infarction: Treatment with thrombectomy and abciximab. Rev Port Cardiol. 2014;33(7–8):465.e1–465.e4. doi:10.1016/j.repc.2014.01.020.
  • Badak O, Guneri S, Kirimli O, Goldeli O, Aslan O, Ozsan H. Primary stenting in a patient with acute myocardial infarction and primary antiphospholipid syndrome. J Invasive Cardiol. 2002;14(4):194–197.
  • Lee YH, Yang HM, Tahk SJ, et al. Recurrent stent thrombosis in a patient with antiphospholipid syndrome and dual anti-platelet therapy non-responsiveness. Korean Circ J. 2015;45(1):71–76. doi:10.4070/kcj.2015.45.1.71.
  • Perl L, Netzer A, Rechavia E, et al. Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention. Cardiology. 2012;122(2):76–82. doi:10.1159/000338347.
  • Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349(12):1133–1138. doi:10.1056/NEJMoa035241.
  • Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005;3(5):848–853. doi:10.1111/j.1538-7836.2005.01340.x.
  • Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6):454S–545S. doi:10.1378/chest.08-0658.
  • Bala MM, Celinska-Lowenhoff M, Szot W, et al. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database Syst Rev. 2017;10:CD012169.
  • Cohen H, Hunt BJ, Efthymiou M, et al. RAPS trial investigators. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial. Lancet Haematol. 2016;3(9):e426–e436. doi:10.1016/S2352-3026(16)30079-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.